SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

bioAffinity Technologies, Inc. – IPO: ‘S-1/A’ on 5/25/22 – ‘EX-3.1’

On:  Wednesday, 5/25/22, at 6:18am ET   ·   Accession #:  1493152-22-14997   ·   File #:  333-264463

Previous ‘S-1’:  ‘S-1’ on 4/25/22   ·   Next:  ‘S-1/A’ on 6/16/22   ·   Latest:  ‘S-1’ on 4/4/24   ·   19 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/25/22  bioAffinity Technologies, Inc.    S-1/A                 33:61M                                    M2 Compliance LLC/FA

Initial Public Offering (IPO):  Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   1.47M 
                (General Form)                                                   
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    176K 
 3: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     23K 
 4: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     18K 
 5: EX-3.3      Articles of Incorporation/Organization or Bylaws    HTML     24K 
 6: EX-3.4      Articles of Incorporation/Organization or Bylaws    HTML     13K 
 7: EX-3.5      Articles of Incorporation/Organization or Bylaws    HTML     57K 
 8: EX-3.6      Articles of Incorporation/Organization or Bylaws    HTML     91K 
16: EX-4.10     Instrument Defining the Rights of Security Holders  HTML     40K 
17: EX-4.11     Instrument Defining the Rights of Security Holders  HTML     33K 
 9: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     13K 
10: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     41K 
11: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     62K 
12: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     80K 
13: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     93K 
14: EX-4.8      Instrument Defining the Rights of Security Holders  HTML    130K 
15: EX-4.9      Instrument Defining the Rights of Security Holders  HTML     20K 
18: EX-10.1     Material Contract                                   HTML     74K 
27: EX-10.10    Material Contract                                   HTML     38K 
19: EX-10.2     Material Contract                                   HTML     16K 
20: EX-10.3     Material Contract                                   HTML     15K 
21: EX-10.4     Material Contract                                   HTML     16K 
22: EX-10.5     Material Contract                                   HTML     15K 
23: EX-10.6     Material Contract                                   HTML     16K 
24: EX-10.7     Material Contract                                   HTML     18K 
25: EX-10.8     Material Contract                                   HTML     24K 
26: EX-10.9     Material Contract                                   HTML     12K 
28: EX-14.1     Code of Ethics                                      HTML     20K 
30: EX-21.1     Subsidiaries List                                   HTML     11K 
31: EX-23.2     Consent of Expert or Counsel                        HTML     12K 
32: EX-23.3     Consent of Expert or Counsel                        HTML     11K 
33: EX-FILING FEES  Filing Fees                                     HTML     35K 
29: EX-16.1     Letter re: a Change in Accountant                   HTML     11K 


‘EX-3.1’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

EXHIBIT 3.1

 

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF

BIOAFFINITY TECHNOLOGIES, INC.

 

I, the undersigned, for the purpose of creating and organizing a corporation under the provisions of and subject to the requirements of the General Corporation Law of the State of Delaware (the “DGCL”), certify as follows:

 

1.The name of the corporation is bioAffinity Technologies, Inc. (the “Corporation”).

 

2.The address of the registered office of the Corporation in the State of Delaware is 1675 South State Street, Suite B, Dover, Kent County, Delaware 19901. The name of the registered agent of the Corporation at such address is Capitol Services, Inc.

 

3.The nature of the business or purposes to be conducted or promoted by the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL.

 

4.The total number of shares of common stock which the corporation is authorized to issue is 100,000,000, at a par value of $0.001 per share and the total number of shares of preferred stock which the corporation is authorized to issue is 20,000,000, at a par value of $0.001 per share.

 

5.The board of directors is hereby expressly authorized to provide, out of the unissued shares of preferred stock, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.

 

6.The name and mailing address of the incorporator of the Corporation is:

 

  Name Mailing Address
     
 

Wilhelm E. Liebmann

c/o Cox Smith Matthews Inc.

112 East Pecan Street, Suite 1800

San Antonio, Texas 78205

 

7.Unless and except to the extent that the by-laws of the Corporation (the “By-laws”) shall so require, the election of directors of the Corporation need not be by written ballot.

 

8.To the fullest extent permitted by law, a director of the Corporation shall not be personally liable to the Corporation or to its stockholders for monetary damages for any breach of fiduciary duty as a director. No amendment to, modification of or repeal of this paragraph seven shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment.

 

 C: 
 
 

 

9.The Corporation shall indemnify, advance expenses, and hold harmless, to the fullest extent permitted by applicable law as it presently exists or may hereafter be amended, any person (a “Covered Person”) who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a “Proceeding”), by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the Corporation or, while a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, enterprise or nonprofit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys’ fees) reasonably incurred by such Covered Person. Notwithstanding the preceding sentence, except for claims for indemnification (following the final disposition of such Proceeding) or advancement of expenses not paid in full, the Corporation shall be required to indemnify a Covered Person in connection with a Proceeding (or part thereof) commenced by such Covered Person only if the commencement of such Proceeding (or part thereof) by the Covered Person was authorized in the specific case by the board of directors of the Corporation. Any amendment, repeal or modification of this paragraph 8 shall not adversely affect any right or protection hereunder of any person in respect of any act or omission occurring prior to the time of such repeal or modification.

 

10.In furtherance and not in limitation of the powers conferred by statute, the Board of Directors is expressly authorized to adopt, amend or repeal the By-laws or adopt new By-laws without any action on the part of the stockholders; provided that any By-law adopted or amended by the board of directors, and any powers thereby conferred, may be amended, altered or repealed by the stockholders.

 

11.The Corporation shall have the right, subject to any express provisions or restrictions contained in the Certificate of Incorporation of the Corporation (the “Certificate of Incorporation”) or the By-laws, from time to time, to amend, alter or repeal any provision of the Certificate of Incorporation in any manner now or hereafter provided by law, and all rights and powers of any kind conferred upon a director or stockholder of the Corporation by the Certificate of Incorporation or any amendment thereof are conferred subject to such right.

 

12.Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim for breach of a fiduciary duty owed by any director, officer, employee or agent of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, the Certificate of Incorporation or the By-laws or (iv) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein.

 

[SIGNATURE PAGE FOLLOWS]

 

 C: 
 C: 2
 

 

I, THE UNDERSIGNED, being the incorporator, for the purpose of forming a corporation pursuant to the DGCL, do make this Certificate of Incorporation, hereby acknowledging, declaring, and certifying that the foregoing Certificate of Incorporation is my act and deed and that the facts herein stated are true, and have accordingly hereunto set my hand this 26th day of March, 2014.

 

  Incorporator
   
  By: /s/ Wilhelm E. Liebmann
  Name: Wilhelm E. Liebmann

 

 C: 
3

 


18 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/05/24  bioAffinity Technologies, Inc.    POS AM                 2:173K                                   M2 Compliance LLC/FA
 4/04/24  bioAffinity Technologies, Inc.    S-1                   77:7.6M                                   M2 Compliance LLC/FA
 4/02/24  bioAffinity Technologies, Inc.    POS AM                75:7.5M                                   M2 Compliance LLC/FA
 4/01/24  bioAffinity Technologies, Inc.    10-K       12/31/23   88:7.5M                                   M2 Compliance LLC/FA
11/16/23  bioAffinity Technologies, Inc.    S-3                    6:1.5M                                   M2 Compliance LLC/FA
11/14/23  bioAffinity Technologies, Inc.    10-Q        9/30/23   68:5.4M                                   M2 Compliance LLC/FA
11/03/23  bioAffinity Technologies, Inc.    S-8 POS    11/03/23    2:70K                                    M2 Compliance LLC/FA
10/18/23  bioAffinity Technologies, Inc.    S-8        10/18/23    4:102K                                   M2 Compliance LLC/FA
 9/20/23  bioAffinity Technologies, Inc.    S-1                   88:10M                                    M2 Compliance LLC/FA
 8/14/23  bioAffinity Technologies, Inc.    10-Q        6/30/23   58:4.6M                                   M2 Compliance LLC/FA
 8/14/23  bioAffinity Technologies, Inc.    DRS9/20/23    1:2.7M                                   M2 Compliance LLC/FA
 4/19/23  bioAffinity Technologies, Inc.    S-8         4/19/23    4:161K                                   M2 Compliance LLC/FA
 3/31/23  bioAffinity Technologies, Inc.    10-K       12/31/22   75:5.4M                                   M2 Compliance LLC/FA
 8/18/22  bioAffinity Technologies, Inc.    S-1/A                 10:7M                                     M2 Compliance LLC/FA
 8/05/22  bioAffinity Technologies, Inc.    S-1/A                  9:6.7M                                   M2 Compliance LLC/FA
 8/02/22  bioAffinity Technologies, Inc.    S-1/A                  3:209K                                   M2 Compliance LLC/FA
 7/28/22  bioAffinity Technologies, Inc.    S-1/A                 17:7.3M                                   M2 Compliance LLC/FA
 6/16/22  bioAffinity Technologies, Inc.    S-1/A                 13:8.5M                                   M2 Compliance LLC/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/25/22  bioAffinity Technologies, Inc.    S-1                    6:5.2M                                   M2 Compliance LLC/FA
Top
Filing Submission 0001493152-22-014997   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 3:49:07.2am ET